Compare ENTA & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | DIN |
|---|---|---|
| Founded | 1995 | 1958 |
| Country | United States | United States |
| Employees | N/A | 992 |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.6M | 360.0M |
| IPO Year | 2012 | 1994 |
| Metric | ENTA | DIN |
|---|---|---|
| Price | $15.22 | $28.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | $20.40 | ★ $29.00 |
| AVG Volume (30 Days) | 123.3K | ★ 343.6K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | ★ 29.93 | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | $102,814,000.00 | ★ $879,300,000.00 |
| Revenue This Year | $7.76 | $3.61 |
| Revenue Next Year | N/A | $0.64 |
| P/E Ratio | ★ N/A | $50.18 |
| Revenue Growth | ★ 16.48 | 8.25 |
| 52 Week Low | $5.55 | $19.58 |
| 52 Week High | $17.15 | $39.68 |
| Indicator | ENTA | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 67.77 | 53.18 |
| Support Level | $12.91 | $24.09 |
| Resistance Level | $15.37 | $28.57 |
| Average True Range (ATR) | 0.76 | 1.57 |
| MACD | 0.16 | 0.10 |
| Stochastic Oscillator | 81.47 | 50.97 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.